Related Experiment Video
Updated: Jul 16, 2026
10:22
Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Management of malaria: recent trends
The Journal of Communicable Diseases
|March 21, 2007
Summary
Effective malaria treatment combines artemisinin derivatives with other drugs, especially for drug-resistant falciparum malaria. Prompt diagnosis and appropriate therapies, including parenteral options in ICUs, are crucial for survival.
Area of Science:
- Infectious Diseases
- Tropical Medicine
- Pharmacology
Background:
- Malaria resurgence and increasing drug resistance necessitate updated treatment strategies.
- Falciparum malaria remains the most lethal form, requiring effective interventions.
- Accurate diagnosis and timely treatment are critical to prevent high mortality rates.
Purpose of the Study:
- To review current effective treatment options for various malaria infections, including drug-resistant strains.
- To highlight the importance of specific drug combinations and prophylactic measures.
- To discuss advanced management strategies for complicated and severe malaria cases.
Main Methods:
- Review of existing literature on antimalarial drug efficacy.
- Analysis of treatment protocols for drug-sensitive and drug-resistant malaria.
- Examination of therapeutic approaches in intensive care unit (ICU) settings.
Main Results:
- Artemisinin combination therapy is the most effective against falciparum malaria.
- Specific drug combinations (e.g., Quinine with doxycycline/clindamycin, Mefloquine with artemeter/artesunate) show efficacy against resistant strains.
- Parenteral artemisinin and quinine are effective in ICU settings, with careful monitoring required.
- Primaquine is essential for preventing relapses of P. vivax, P. ovale, and P. malariae.
Conclusions:
- Combination therapies are key to managing drug-resistant malaria.
- Prompt diagnosis and treatment, including specialized ICU care, significantly improve outcomes.
- Adherence to recommended treatment regimens and prophylactic measures is vital for malaria control.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...